Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 180 Lymphoma 134 Sarcoma 80 Lymphoma, Large B-Cell, Diffuse 79 Precursor Cell Lymphoblastic Leukemia-Lymphoma 70 Hodgkin Disease 50 Lymphoma, Non-Hodgkin 49 Leukemia 41 Burkitt Lymphoma 40 Lymphoma, Mantle-Cell 37 Lymphoma, Follicular 34 Neuroblastoma 30 Ovarian Neoplasms 26 Multiple Myeloma 26 Neoplasms 24 Lymphoma, Large-Cell, Anaplastic 23 Carcinoma, Hepatocellular 23 Neoplasm Metastasis 20 Lymphoma, Large-Cell, Immunoblastic 19 Triple Negative Breast Neoplasms 18 HIV Infections 18 Urinary Bladder Neoplasms 15 Acquired Immunodeficiency Syndrome 15 Osteosarcoma 14 Liposarcoma 14 Leiomyosarcoma 13 Histiocytoma, Malignant Fibrous 13 Breast Neoplasms, Male 13 Lymphoma, B-Cell, Marginal Zone 12 Inflammatory Breast Neoplasms 12

Interventions

Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prosthesis Failure × Doxorubicin × Clear all

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡